PR Newswire

New AI-powered mobihome service gives customers stronger WiFi, advanced protection and greater control at no additional cost PALO ALTO, Calif. and ULAANBAATAR, Mongolia, Sept. 9, 2026 /PRNewswire/ -- Plume Design, Inc. ("Plume"), the award-winning global subscriber experience platform serving more t

New Generation, New Cinematic Language: Osmo Pocket 4P Sparks a New Conversation About Storytelling, Creative Freedom, and Professional Tools. VENICE, Italy, Sept. 9, 2026 /PRNewswire/ -- DJI, the global leader in civilian drones and creative camera technology, hosted the "Filmmakers & Visionaries S

PRINCETON, N.J. and SUZHOU, China, Sept. 9, 2026 /PRNewswire/ -- Transcenta Therapeutics (HKEX: 06628), a global clinical-stage biopharmaceutical company with fully integrated capabilities in discovery, R&D and process development of antibody-based therapeutics, today announced that it and its subsi

Leverages fermentation know-how developed through MIWON to expand beyond general-purpose amino acids into high-value pharmaceutical materials Acquires Germany-based AMINO GmbH, gaining purification technology, European regulatory expertise, and a global customer network SEOUL, South Korea, Sept. 9,

NYON, Switzerland, Sept. 9, 2026 /PRNewswire/ -- Hublot proudly announces an extraordinary collaboration with world-renowned artist Jeff Koons. A partnership made to take shape. Both Koons and Hublot operate on the same principle: transforming tension into form; contradiction into harmony; excess in

HR Path, a global leader in Human Resources, announces the acquisition of tts digital HR experts GmbH, a specialist in SAP SuccessFactors and SAP HCM consulting, implementation and application management. The addition strengthens HR Path's SAP SuccessFactors capabilities, expands its delivery capaci

SHANGHAI, Sept. 9, 2026 /PRNewswire/ -- LattePanda Team today launched LattePanda Mu Ultra, a micro x86 compute module purpose-built for on-device AI. Powered by Intel Core Ultra 5 226V and Ultra 7 256V processors, it delivers up to 115 TOPS of AI performance in a compact 69.6 × 60mm form factor. Bu

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept. 9, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biot

Porustobart, a second-generation Fc-enhanced CTLA-4 antibody, is being advanced across two clinical indications in the neoadjuvant setting, beginning with MSS clinical stage II-III colon cancer Phase 2 trial of porustobart for colon cancer will be open for enrollment early in the fourth quarter of 2

Douyin licensing partnership with 3Z LIVE creates a cross-border route into China's short-video market. Talent management and entertainment company pairs production facilities and operational management with commercial representation, giving creators a route from platform income to diversified reven